Related references
Note: Only part of the references are listed.Idebenone Protects against Atherosclerosis in Apolipoprotein E-Deficient Mice Via Activation of the SIRT3-SOD2-mtROS Pathway
Wei Jiang et al.
CARDIOVASCULAR DRUGS AND THERAPY (2021)
Effectiveness of idebenone nanorod formulations in the treatment of Alzheimer's disease
Yuying Huang et al.
JOURNAL OF CONTROLLED RELEASE (2021)
A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease
Daniela Hartl et al.
MOLECULAR PSYCHIATRY (2020)
Degradome of soluble ADAM10 and ADAM17 metalloproteases
Franka Scharfenberg et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease
Balmiki Ray et al.
TRANSLATIONAL PSYCHIATRY (2020)
Synthetic fragment (60-76) of RAGE improves brain mitochondria function in olfactory bulbectomized mice
Armine Avetisyan et al.
NEUROCHEMISTRY INTERNATIONAL (2020)
Idebenone protects mitochondrial function against amyloid beta toxicity in primary cultured cortical neurons
Huiting Wang et al.
NEUROREPORT (2020)
CoQ(10) Deficient Endothelial Cell Culture Model for the Investigation of CoQ(10) Blood-Brain Barrier Transport
Luke Wainwright et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Activation of ADAM17 (A Disintegrin and Metalloprotease 17) on Glutamatergic Neurons Selectively Promotes Sympathoexcitation
Jiaxi Xu et al.
HYPERTENSION (2019)
RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity
Fang Fang et al.
HUMAN MOLECULAR GENETICS (2018)
RAGE-dependent mitochondria pathway: a novel target of silibinin against apoptosis of osteoblastic cells induced by advanced glycation end products
Y. X. Mao et al.
CELL DEATH & DISEASE (2018)
Levels of ADAM10 are reduced in Alzheimer's disease CSF
Aitana Sogorb-Esteve et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease
Ahsan Habib et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2017)
Bile acid TUDCA improves insulin clearance by increasing the expression of insulin-degrading enzyme in the liver of obese mice
Jean Franciesco Vettorazzi et al.
SCIENTIFIC REPORTS (2017)
The Role of APP in Structural Spine Plasticity
Elena Montagna et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Alzheimer's Disease and the Amyloid-β Peptide
M. Paul Murphy et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Amyloid beta: structure, biology and structure-based therapeutic development
Guo-fang Chen et al.
ACTA PHARMACOLOGICA SINICA (2017)
The APP Intracellular Domain Is Required for Normal Synaptic Morphology, Synaptic Plasticity, and Hippocampus-Dependent Behavior
Maja Klevanski et al.
JOURNAL OF NEUROSCIENCE (2015)
Schisandrin B Ameliorates ICV-Infused Amyloid β Induced Oxidative Stress and Neuronal Dysfunction through Inhibiting RAGE/NF-κB/MAPK and Up-Regulating HSP/Beclin Expression
Vijayasree V. Giridharan et al.
PLOS ONE (2015)
Upregulation of APP, ADAM10 and ADAM17 in the Denervated Mouse Dentate Gyrus
Domenico Del Turco et al.
PLOS ONE (2014)
Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis
George S. Bloom
JAMA NEUROLOGY (2014)
Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease
Bo-Ryoung Choi et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2014)
Intracranial Injection of AAV Expressing NEP but Not IDE Reduces Amyloid Pathology in APP+PS1 Transgenic Mice
Nikisha Carty et al.
PLOS ONE (2013)
Coenzyme Q10 Ameliorates Pain and Cartilage Degradation in a Rat Model of Osteoarthritis by Regulating Nitric Oxide and Inflammatory Cytokines
Jennifer Lee et al.
PLOS ONE (2013)
Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease
Sang-Sun Yoon et al.
BIOMOLECULES & THERAPEUTICS (2012)
The Upside of APP at Synapses
Hyang-Sook Hoe et al.
CNS NEUROSCIENCE & THERAPEUTICS (2012)
Thioredoxin-80 is a product of alpha-secretase cleavage that inhibits amyloid-beta aggregation and is decreased in Alzheimer's disease brain
Francisco Gil-Bea et al.
EMBO MOLECULAR MEDICINE (2012)
Knock-down of protein L-isoaspartyl O-methyltransferase increases β-amyloid production by decreasing ADAM10 and ADAM17 levels
Narkhyun Bae et al.
ACTA PHARMACOLOGICA SINICA (2011)
Tau in Alzheimer Disease and Related Tauopathies
K. Iqbal et al.
CURRENT ALZHEIMER RESEARCH (2010)
ADAM10 is the physiologically relevant, constitutive α-secretase of the amyloid precursor protein in primary neurons
Peer-Hendrik Kuhn et al.
EMBO JOURNAL (2010)
Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain
Suqing Wang et al.
JOURNAL OF NEUROCHEMISTRY (2010)
RAGE-induced Cytosolic ROS Promote Mitochondrial Superoxide Generation in Diabetes
Melinda T. Coughlan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
RAGE-mediated signaling contributes to intraneuronal transport of amyloid-β and neuronal dysfunction
Kazuhiro Takuma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
C. -X. Gong et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy
James Scott Miners et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease
John E. Donahue et al.
ACTA NEUROPATHOLOGICA (2006)
Neprilysin-sensitive synapse-associated amyloid-β peptide oligomers impair neuronal plasticity and cognitive function
Shu-Ming Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
W Farris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Metabolic regulation of brain Aβ by neprilysin
N Iwata et al.
SCIENCE (2001)
Share Paper
